| Nucleotide reverse transcriptase inhibitors: a thorough review, present status and future perspective as HIV therapeutics AD Holec, S Mandal, PK Prathipati, CJ Destache Current HIV research 15 (6), 411-421, 2017 | 95 | 2017 |
| Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening A Pattnaik, N Palermo, BR Sahoo, Z Yuan, D Hu, AS Annamalai, HLX Vu, ... Antiviral research 151, 78-86, 2018 | 61 | 2018 |
| Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission S Mandal, PK Prathipati, G Kang, Y Zhou, Z Yuan, W Fan, Q Li, ... Aids 31 (4), 469-476, 2017 | 54 | 2017 |
| Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against … S Mandal, G Kang, PK Prathipati, Y Zhou, W Fan, Q Li, CJ Destache Journal of controlled release 294, 216-225, 2019 | 40 | 2019 |
| Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection AN Pandya, PK Prathipati, P Hegde, W Li, KF Graham, S Mandal, ... Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 02245-18, 2019 | 37 | 2019 |
| Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model study S Mandal, G Kang, PK Prathipati, W Fan, Q Li, CJ Destache Antiviral research 156, 85-91, 2018 | 37 | 2018 |
| Pharmacokinetic and tissue distribution profile of long acting tenofovir alafenamide and elvitegravir loaded nanoparticles in humanized mice model PK Prathipati, S Mandal, G Pon, R Vivekanandan, CJ Destache Pharmaceutical research 34, 2749-2755, 2017 | 36 | 2017 |
| Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC–MS/MS and its application to a … PK Prathipati, S Mandal, CJ Destache Journal of pharmaceutical and biomedical analysis 129, 473-481, 2016 | 36 | 2016 |
| A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study S Mandal, PK Prathipati, M Belshan, CJ Destache Antiviral research 167, 83-88, 2019 | 31 | 2019 |
| Development, validation of liquid chromatography-tandem mass spectrometry method for simultaneous determination of rosuvastatin and metformin in human plasma and its … PP Kumar, T Murthy, MVB Rao Journal of Advanced Pharmaceutical Technology & Research 6 (3), 118-124, 2015 | 22 | 2015 |
| Cellulose acetate phthalate and antiretroviral nanoparticle fabrications for HIV pre-exposure prophylaxis S Mandal, K Khandalavala, R Pham, P Bruck, M Varghese, A Kochvar, ... Polymers 9 (9), 423, 2017 | 20 | 2017 |
| Development and validation of LC–MS/MS method for quantification of bictegravir in human plasma and its application to an intracellular uptake study PK Prathipati, S Mandal, CJ Destache Biomedical Chromatography 33 (2), e4379, 2019 | 19 | 2019 |
| Synthesis, Antimicrobial and Antihyperlipidemic Activities of Some 4-Substituted-5, 6, 7, 8-tetrahydro [1] benzothieno [2, 3-d] pyrimidines VH Bhaskar, PP Kumar, B Sangameshwaran Asian Journal of Chemistry 19 (7), 5187, 2007 | 17 | 2007 |
| Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors CM Stevens, SO Babii, AN Pandya, W Li, Y Li, J Mehla, R Scott, P Hegde, ... Proceedings of the National Academy of Sciences 119 (30), e2113963119, 2022 | 10 | 2022 |
| Formulation and characterization of ternary amorphous solid dispersions of a highly potent anti-tubercular agent and curcumin S Borde, P Hegde, P Prathipati, J North, D Kumari, H Chauhan Journal of Drug Delivery Science and Technology 64, 102564, 2021 | 10 | 2021 |
| A concept evaluation study of a new combination bictegravir plus tenofovir alafenamide nanoformulation with prolonged sustained-drug-release potency for HIV-1 preexposure … S Mandal, PK Prathipati, SW Sunagawa, CJ Destache Antimicrobial agents and chemotherapy 65 (4), 10.1128/aac. 02320-20, 2021 | 7 | 2021 |
| Surface plasmon resonance, Orbitrap mass spectrometry and Raman advancements: exciting new techniques in drug discovery GP Jadhav, PK Prathipati, H Chauhan Expert Opinion on Drug Discovery 15 (7), 739-743, 2020 | 7 | 2020 |
| A review of CCR5 antibodies against HIV: current and future aspects PK Prathipati, S Mandal, CJ Destache Therapeutic delivery 10 (2), 107-112, 2019 | 7 | 2019 |
| Bictegravir plus tenofovir alafenamide nanoformulation as a long-acting pre-exposure prophylaxis regimen: application of modeling to design non-human primate pharmacokinetic … S Perazzolo, S Mandal, PK Prathipati, CJ Destache Frontiers in Pharmacology 11, 603242, 2020 | 6 | 2020 |
| LC–MS/MS method for the simultaneous determination of tenofovir, emtricitabine, elvitegravir and rilpivirine in dried blood spots PK Prathipati, S Mandal, CJ Destache Biomedical Chromatography 32 (9), e4270, 2018 | 6 | 2018 |
Subhra MandalResident Assistant Professor, University of Nebraska-Lincoln, School of Biological Sciences, LincolnVerified email at unl.edu
